ECDC issues guidance on integrated HIV, HBV, and HCV testing

  • European Centre for Disease Prevention and Control

  • curated by Emily Willingham, PhD
  • Medical News
Access to the full content of this site is available only to registered healthcare professionals. Access to the full content of this site is available only to registered healthcare professionals.

Takeaway

  • The European Centre for Disease Prevention and Control (ECDC) has issued evidence-based guidance for screening for HIV, HBV, and HCV infections, using an integrated approach.

Why this matters

  • The ECDC is acting to support the global goal of eliminating these viruses by 2030.
  • Though early treatment is critical, 1 in 2 HIV cases is not identified until later stages, and about 9 million Europeans are unaware of their chronic HBV or HCV infection.

Key guidance

  • Infection with 1 virus can increase risk for another, supporting the need to test for all 3 simultaneously.
  • Each nation needs an integrated testing strategy that includes 6 key principles:
    • Testing is accessible, voluntary, confidential, and contingent on informed consent. 
    • Appropriate information offered before and after testing.
    • Testing is linked to care.
    • Testing is normalized in health care setting.
    • Appropriate training offered for test providers.
    • National monitoring and evaluation framework is established.
  • Target populations include men who have sex with men; sex workers; people who inject drugs, receive blood products, are pregnant, are in prison, or have sexual or injecting partners with infection.
  • Testing should be provided in primary care, at clinics, pharmacies, and prisons, in the community, and as self-testing.

Please confirm your acceptance

To gain full access to GPnotebook please confirm:

By submitting here you confirm that you have accepted Terms of Use and Privacy Policy of GPnotebook.

Submit